The effect of taxifolin on cisplatin induced oxidative cochlear damage in rats: Biochemical and histopathological examination

ArticleAçık Erişim

Özet

Ototoxicity of cisplatin is one of the major dose-limiting side effects. Cisplatin-dependent ototoxic-ity is known to be associated with reactive oxygen species. Protective effect of taxifolin, being a flavanone found in onions, milk thistle, French maritime, and Douglas fir bark, against cisplatin-associated ototoxicity will be examined in this study. There are no studies in the literature examining the protective effect of taxifolin against cisplatin-induced ototoxicity. 50 mg/kg taxifolin was orally administered to TXC group rats (n-6), and distilled water was orally administered as a solvent to CG (n-6) and HG (n-6) groups. One hour later, 5 mg/kg cisplatin was administered intraperitoneally (i.p) to TXC and CG groups. This procedure was repeated once a day for 7 days. At the end of this period, all animals were sacrificed by high-dose anesthesia (50 mg/kg thiopen-tal sodium) and biochemical and histopathological examinations were performed on the dissected cochlear tissue. Our biochemical test results showed that oxidant parameters were significantly increased whereas antiox-idant parameters were significantly decreased in the cisplatin group (CG) compared to taxifolin (TXC) and healthy (HG) groups (p < 0.0001 for both parameters). Histopathological results showed that severe cochlear vestibular membrane degeneration, dilated conjunctival blood vessels, edema and destruction developed in the cisplatin group. However, no pathological findings were found in the taxifolin-treated group except for mild degeneration and edema. This information suggests that taxifolin may be useful in the treatment of cisplatin-associated oxidative cochlear damage. © 2019 Polish Pharmaceutical Society. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14068Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.32383/appdr/110616Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorErhan, Ertugrul
dc.contributor.authorBayram, Rana
dc.contributor.authorCimen, Ferda Keskin
dc.contributor.authorAltuner, Durdu
dc.contributor.authorSeckin, Ender
dc.contributor.authorKurt, Nezahat
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:28:51.332263237Z
dc.date.available2026-10-18T20:28:51.332263237Z
dc.date.issued2019
dc.description.abstractOtotoxicity of cisplatin is one of the major dose-limiting side effects. Cisplatin-dependent ototoxic-ity is known to be associated with reactive oxygen species. Protective effect of taxifolin, being a flavanone found in onions, milk thistle, French maritime, and Douglas fir bark, against cisplatin-associated ototoxicity will be examined in this study. There are no studies in the literature examining the protective effect of taxifolin against cisplatin-induced ototoxicity. 50 mg/kg taxifolin was orally administered to TXC group rats (n-6), and distilled water was orally administered as a solvent to CG (n-6) and HG (n-6) groups. One hour later, 5 mg/kg cisplatin was administered intraperitoneally (i.p) to TXC and CG groups. This procedure was repeated once a day for 7 days. At the end of this period, all animals were sacrificed by high-dose anesthesia (50 mg/kg thiopen-tal sodium) and biochemical and histopathological examinations were performed on the dissected cochlear tissue. Our biochemical test results showed that oxidant parameters were significantly increased whereas antiox-idant parameters were significantly decreased in the cisplatin group (CG) compared to taxifolin (TXC) and healthy (HG) groups (p < 0.0001 for both parameters). Histopathological results showed that severe cochlear vestibular membrane degeneration, dilated conjunctival blood vessels, edema and destruction developed in the cisplatin group. However, no pathological findings were found in the taxifolin-treated group except for mild degeneration and edema. This information suggests that taxifolin may be useful in the treatment of cisplatin-associated oxidative cochlear damage. © 2019 Polish Pharmaceutical Society. All rights reserved.
dc.identifier.doi10.32383/appdr/110616
dc.identifier.eissn2353-5288
dc.identifier.endpage900
dc.identifier.issn0001-6837
dc.identifier.issue5
dc.identifier.scopus2-s2.0-85074581425
dc.identifier.startpage895
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14068
dc.identifier.volume76
dc.identifier.wosWOS:000493781500013
dc.language.isoen
dc.publisherPolish Pharmaceutical Society
dc.relation.ispartofActa Poloniae Pharmaceutica - Drug Research
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCisplatin
dc.subjectCochlear damage
dc.subjectRats
dc.subjectTaxifolin
dc.subjectdistilled water
dc.subjectglutathione
dc.subjectmalonaldehyde
dc.subjectthiopental
dc.subjectanimal experiment
dc.subjectArticle
dc.subjectchemosis
dc.subjectcochlea injury
dc.subjectcochlea tissue
dc.subjectcontrolled study
dc.subjectdrug effect
dc.subjecthistopathology
dc.subjectmale
dc.subjectnonhuman
dc.subjectrat
dc.titleThe effect of taxifolin on cisplatin induced oxidative cochlear damage in rats: Biochemical and histopathological examination
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.wos2
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)